Rdhl earnings
WebApr 5, 2024 · Redhill Biopharma ( RDHL) is scheduled to report earnings on June 22, 2024. The last reported earnings were for reported on November 29, 2024 for Q3. Q What were … WebRedHill Biopharma (RDHL) Earnings Date & Reports 615 Followers Portfolio Earnings Data Report Date Feb 22, 2024 Not Confirmed Period Ending 2024 (Q4) Consensus EPS …
Rdhl earnings
Did you know?
WebEarnings Date: Apr 14, 2024 - Apr 15, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 40.00: All. News. ... (Nasdaq:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the Radiation and Nuclear Countermeasures Program (RNCP), of the National Institute of Allergy and ... WebApr 13, 2024 · RedHill Biopharma (NASDAQ:RDHL) has a market capitalization of $7.73 million and generates $85.76 million in revenue each year. The biotechnology company …
WebJan 24, 2024 · RedHill Biopharma (RDHL) Analysts Prediction, Stock Forecast & Price Targets - Simply Wall St View Valuation RedHill Biopharma Future Growth Future criteria checks 0/6 We currently don’t have sufficient analyst coverage to forecast growth and revenue for RedHill Biopharma. Key information 50.8% Earnings growth rate 65.3% EPS … WebRDHL -6.33% DJIA 0.43% Russell 2K -0.18% Health Care/Life Sciences 0.64% Overview Earnings & Estimates RedHill Biopharma Ltd. ADR Per Share Data RedHill Biopharma Ltd. ADR All values...
WebRDHL earnings and revenue history Current Revenue $76.2M Current Earnings -$88.9M Current Profit Margin -116.7% RDHL Return on Equity Current Company N/A Current … WebRedHill Biopharma Ltd (RDHL) Price & News - Google Finance +$19.00 Gold $70.37 -$0.53 Home RDHL • NASDAQ RedHill Biopharma Ltd Follow Share $5.60 Pre-market: $5.00 (10.65%) -0.60 Closed: Mar...
WebMar 10, 2024 · RDHL RedHill Biopharma Ltd.Earnings Date & History. $0.20 -0.0093 ( -4.49%) 3:59 PM 03/10/23. NASDAQ $USD Market Close. Summary.
WebRedHill Biopharma Ltd. (RDHL) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 4.0900 -0.3500 (-7.88%) At close: 03:59PM EDT. 4.2200 +0.13 … how i treat mgusWebSee RedHill Biopharma Ltd. (RDHL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. how i treat jmmlWebEarnings growth (last year) +0.17%. Earnings growth (this year) +96.67%. Earnings growth (next 5 years) +113.00%. Revenue growth (last year) +32.41%. P/E ratio. how i treat low grade glioma childrenWebApr 14, 2024 · RedHill Biopharma NasdaqGM:RDHL Stock Report Last Price US$3.26 Market Cap US$7.4m 7D -26.6% 1Y -96.7% Updated 06 Apr, 2024 Data Company Financials + 1 Analyst RDHL Stock Overview RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. About the … how i treat marginal zone lymphoma ashWebFind real-time RDHL - Redhill Biopharma Ltd stock quotes, company profile, news and forecasts from CNN Business. ... Earnings growth (this year) +96.67%: Earnings growth (next 5 years) how i treat lung gvhdWebMar 2, 2024 · RedHill Biopharma (NASDAQ:RDHL) has a recorded net income of -$97.74 million. RDHL has generated -$1.56 earnings per share over the last four quarters. What is … how i treat lymphomatoid granulomatosisWebTrade RDHL with: Price/Earnings ttm 0.00 Earnings Per Share ttm -62.40 Most Recent Earnings -22.40 on 11/29/22 Next Earnings Date 04/06/23 Annual Dividend & Yield 0.00 (0.00%) Most Recent Dividend N/A on N/A Sectors: SIC-2834 Pharmaceutical Preparations Medical - Drugs Bottom 100 Stocks Options Overview Details View History how i treat mgrs